Exploring the salt–cocrystal continuum with solid-state NMR using natural-abundance samples: implications for crystal engineering
Source abstract
Abstract
There has been significant recent interest in differentiating multicomponent solid forms, such as salts and cocrystals, and, where appropriate, in determining the position of the proton in theX—H...A—YX−...H—A+—Ycontinuum in these systems, owing to the direct relationship of this property to the clinical, regulatory and legal requirements for an active pharmaceutical ingredient (API). In the present study, solid forms of simple cocrystals/salts were investigated by high-field (700 MHz) solid-state NMR (ssNMR) using samples with naturally abundant15N nuclei. Four model compounds in a series of prototypical salt/cocrystal/continuum systems exhibiting {PyN...H—O—}/{PyN+—H...O−} hydrogen bonds (Py is pyridine) were selected and prepared. The crystal structures were determined at both low and room temperature using X-ray diffraction. The H-atom positions were determined by measuring the15N—1H distances through15N-1H dipolar interactions using two-dimensional inversely proton-detected cross polarization with variable contact-time (invCP-VC)1H→15N→1H experiments at ultrafast (νR≥ 60–70 kHz) magic angle spinning (MAS) frequency. It is observed that this method is sensitive enough to determine the proton position even in a continuum where an ambiguity of terminology for the solid form often arises. This work, while carried out on simple systems, has implications in the pharmaceutical industry where the salt/cocrystal/continuum condition of APIs is considered seriously.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced NMR Techniques and Applications · Solid-state spectroscopy and crystallography · Crystallography and molecular interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (78)
Show source-provided references
1. Aakeröy · Mol. Pharm. · 2007 · 4 · 31710.1021/mp060126o ↗
2. Aakeröy · CrystEngComm · 2005 · 7 · 43910.1039/b505883j ↗
3. Aakeröy · Chem. Soc. Rev. · 1993 · 22 · 39710.1039/CS9932200397 ↗
4. Aitipamula · Cryst. Growth Des. · 2012 · 12 · 214710.1021/cg3002948 ↗
5. Allen · Acta Cryst. B · 2010 · 66 · 38010.1107/S0108768110012048 ↗
6. Almarsson · Chem. Commun. · 2004 · 188910.1039/b402150a ↗
7. Berglund · J. Chem. Phys. · 1980 · 73 · 203710.1063/1.440423 ↗
8. Bhogala · CrystEngComm · 2005 · 7 · 55110.1039/b509162d ↗
9. Bodenhausen · Chem. Phys. Lett. · 1980 · 69 · 18510.1016/0009-2614(80)80041-8 ↗
10. Bond · CrystEngComm · 2007 · 9 · 83310.1039/b708112j ↗
11. Bruker (2006). SAINT-Plus. Bruker AXS Inc., Madison, Wisconsin, USA.
12. Childs · Mol. Pharm. · 2007 · 4 · 32310.1021/mp0601345 ↗
13. Cotton · Inorg. Chem. · 1989 · 28 · 321010.1021/ic00315a025 ↗
14. Cruz-Cabeza · CrystEngComm · 2012 · 14 · 636210.1039/c2ce26055g ↗
15. Desiraju · CrystEngComm · 2003 · 5 · 46610.1039/b313552g ↗
16. Desiraju · J. Am. Chem. Soc. · 2013 · 135 · 995210.1021/ja403264c ↗
17. Desiraju, G. R. & Steiner, T. (1999). In The Weak Hydrogen Bond in Structural Chemistry and Biology. Oxford University Press.
18. Dolomanov · J. Appl. Cryst. · 2009 · 42 · 33910.1107/S0021889808042726 ↗
19. Duggirala · Chem. Commun. · 2016 · 52 · 64010.1039/C5CC08216A ↗
20. Dunitz · CrystEngComm · 2003 · 5 · 50610.1039/b315687g ↗
21. Farrugia · J. Appl. Cryst. · 1999 · 32 · 83710.1107/S0021889899006020 ↗
22. Grobelny · CrystEngComm · 2011 · 13 · 435810.1039/c0ce00842g ↗
23. Groom · Acta Cryst. B · 2016 · 72 · 17110.1107/S2052520616003954 ↗
24. Hartmann · Phys. Rev. · 1962 · 128 · 204210.1103/PhysRev.128.2042 ↗
25. Hathwar · Cryst. Growth Des. · 2010 · 10 · 330610.1021/cg100457r ↗
26. Ikni · Cryst. Growth Des. · 2014 · 14 · 328610.1021/cg500163c ↗
27. Ishii · J. Chem. Phys. · 1997 · 107 · 276010.1063/1.474633 ↗
28. Ishii · J. Am. Chem. Soc. · 2001 · 123 · 292110.1021/ja015505j ↗
29. Jeffrey, G. A. (1997). In An Introduction to Hydrogen Bonding. Oxford University Press.
30. Jeffrey · Acta Cryst. B · 1986 · 42 · 41010.1107/S0108768186098038 ↗
31. Laage · J. Magn. Reson. · 2009 · 196 · 13310.1016/j.jmr.2008.10.019 ↗
32. Ladizhansky · J. Chem. Phys. · 2000 · 112 · 715810.1063/1.481281 ↗
33. Li · J. Am. Chem. Soc. · 2006 · 128 · 819910.1021/ja0541332 ↗
34. Lorente · Magn. Reson. Chem. · 2001 · 39 · S1810.1002/mrc.946 ↗
35. Lusi · Cryst. Growth Des. · 2011 · 11 · 551510.1021/cg201087s ↗
36. Malarski · J. Mol. Struct. · 1987 · 158 · 36910.1016/0022-2860(87)80033-9 ↗
37. Metz · J. Magn. Reson. A · 1994 · 110 · 21910.1006/jmra.1994.1208 ↗
38. Miah · J. Magn. Reson. · 2013 · 235 · 110.1016/j.jmr.2013.07.005 ↗
39. Mukherjee · Cryst. Growth Des. · 2014 · 14 · 137510.1021/cg401851z ↗
40. Müller · J. Am. Chem. Soc. · 1979 · 101 · 448110.1021/ja00510a007 ↗
41. Müller · Phys. Rev. Lett. · 1974 · 32 · 140210.1103/PhysRevLett.32.1402 ↗
42. Nielsen · J. Chem. Phys. · 1994 · 101 · 180510.1063/1.467759 ↗
43. Nishiyama · Solid State Nucl. Magn. Reson. · 2016 · 78 · 2410.1016/j.ssnmr.2016.06.002 ↗
44. Nishiyama · Solid State Nucl. Magn. Reson. · 2016 · 73 · 1510.1016/j.ssnmr.2015.06.005 ↗
45. Otsuka · Drug Dev. Ind. Pharm. · 1994 · 20 · 164910.3109/03639049409050205 ↗
46. Paluch · J. Magn. Reson. · 2013 · 233 · 5610.1016/j.jmr.2013.05.005 ↗
47. Paluch · J. Magn. Reson. · 2015 · 252 · 6710.1016/j.jmr.2015.01.002 ↗
48. Park · J. Magn. Reson. · 2013 · 237 · 16410.1016/j.jmr.2013.10.009 ↗
49. Parkin · New J. Chem. · 2004 · 28 · 71810.1039/b315515c ↗
50. Pirttimäki · Int. J. Pharm. · 1993 · 95 · 9310.1016/0378-5173(93)90394-U ↗
51. Ramamoorthy · J. Magn. Reson. · 1999 · 140 · 13110.1006/jmre.1999.1827 ↗
52. Ramon · CrystEngComm · 2014 · 16 · 580210.1039/C3CE41963K ↗
53. Rigaku (2009). Crystal Clear-SM Expert. Rigaku Corporation, Tokyo, Japan.
54. Roberts · J. Am. Chem. Soc. · 1987 · 109 · 416310.1021/ja00248a006 ↗
55. Rohlfing · J. Chem. Phys. · 1983 · 79 · 495810.1063/1.445589 ↗
56. Rossum · J. Am. Chem. Soc. · 2000 · 122 · 346510.1021/ja992714j ↗
57. Saha · CrystEngComm · 2015 · 17 · 127310.1039/C4CE02034K ↗
58. Schmidtmann · CrystEngComm · 2007 · 9 · 74310.1039/b709136m ↗
59. Schmidt-Rohr, K. & Spiess, H. W. (1994). In Multidimensional Solid-State NMR and Polymers. New York: Academic Press.
60. Shaka · J. Magn. Reson. · 1983 · 53 · 313
61. Shakhtshneider · Drug Dev. Ind. Pharm. · 1993 · 19 · 205510.3109/03639049309069341 ↗
62. Sheldrick · Acta Cryst. A · 2008 · 64 · 11210.1107/S0108767307043930 ↗
63. Silva · Cryst. Growth Des. · 2013 · 13 · 431510.1021/cg400662n ↗
64. Spek · Acta Cryst. D · 2009 · 65 · 14810.1107/S090744490804362X ↗
65. Steiner · Angew. Chem. Int. Ed. · 2001 · 40 · 265110.1002/1521-3773(20010716)40:14<2651::AID-ANIE2651>3.0.CO;2-2 ↗
66. Stevens · Phys. Chem. Chem. Phys. · 2014 · 16 · 115010.1039/C3CP53907E ↗
67. Thomas · Cryst. Growth Des. · 2010 · 10 · 277010.1021/cg100315u ↗
68. US-FDA. (2016). Guidelines, https://www.fda.gov/downloads/Drugs/Guidances/UCM516813.pdf.
69. Vishweshwar · J. Pharm. Sci. · 2006 · 95 · 49910.1002/jps.20578 ↗
70. Wickramasinghe · J. Magn. Reson. · 2007 · 184 · 35010.1016/j.jmr.2006.10.012 ↗
71. Wickramasinghe · Solid State Nucl. Magn. Reson. · 2015 · 72 · 910.1016/j.ssnmr.2015.10.002 ↗
72. Wilson · Angew. Chem. Int. Ed. · 2004 · 43 · 209510.1002/anie.200352650 ↗
73. Wouters, J. & Quéré, L. (2012). In Pharmaceutical Salts and Co-crystals. Cambridge: RSC Publishing.
74. Wu · J. Am. Chem. Soc. · 1998 · 120 · 1318710.1021/ja983126t ↗
75. Yazawa · Chem. Commun. · 2012 · 48 · 1119910.1039/c2cc36300c ↗
76. Ye · J. Magn. Reson. · 2014 · 239 · 7510.1016/j.jmr.2013.12.010 ↗
77. Zhang · J. Magn. Reson. · 2015 · 250 · 3710.1016/j.jmr.2014.10.013 ↗
78. Zhao · J. Am. Chem. Soc. · 2001 · 123 · 1109710.1021/ja016328p ↗